Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franco Grimaldi

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Clinical Endocrinology|September 6, 2012
A new germline VHL gene mutation in three patients with apparently sporadic pheochromocytomaAngela V D'Elia, Franco Grimaldi, Stefano Pizzolitto, et al.
European Journal of Endocrinology|December 24, 2010
CDKN1B V109G polymorphism a new prognostic factor in sporadic medullary thyroid carcinomaDaniela Pasquali, Luisa Circelli, Antongiulio Faggiano, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|November 11, 2008
Effects of lanreotide Autogel on growth hormone, insulinlike growth factor 1, and tumor size in acromegaly: a 1-year prospective multicenter studyRoberto Attanasio, Roberto Lanzi, Marco Losa, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|December 15, 2017
<i>Italian Association of Clinical Endocrinologists (AME) and Italian AACE Chapter Position Statement for Clinical Practice</i>: Assessment of Response to Treatment and Follow-Up in Gastroenteropancreatic Neuroendocrine NeoplasmsFranco Grimaldi, Nicola Fazio, Roberto Attanasio, et al.
Molecular Genetics and Metabolism|July 14, 2012
CASR gene activating mutations in two families with autosomal dominant hypocalcemiaVito Guarnieri, Angela Valentina D'Elia, Filomena Baorda, et al.
Endocrine|June 25, 2013
Growth hormone values after an oral glucose load do not add clinically useful information in patients with acromegaly on long-term somatostatin receptor ligand treatmentGiuseppe Reimondo, Marta Bondanelli, Maria Rosaria Ambrosio, et al.
Journal of Neuroendocrinology|June 2, 2025
Fragility fractures in well-differentiated gastroenteropancreatic neuroendocrine tumors: Results from a multicentered retrospective studyAlessandro Brunetti, Miriam Cellini, Elisabetta Lavezzi, et al.
Advances in Therapy|November 21, 2023
Optimising Radioligand Therapy for Patients with Gastro-Entero-Pancreatic Neuroendocrine Tumours: Expert Opinion from an Italian Multidisciplinary GroupNicola Fazio, Massimo Falconi, Emanuela Foglia, et al.
Plos One|July 15, 2014
AHR over-expression in papillary thyroid carcinoma: clinical and molecular assessments in a series of Italian acromegalic patients with a long-term follow-upCaterina Mian, Filippo Ceccato, Susi Barollo, et al.
Clinical Endocrinology|December 12, 2012
Cinacalcet in the management of primary hyperparathyroidism: post marketing experience of an Italian multicentre groupFederica Saponaro, Antongiulio Faggiano, Franco Grimaldi, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Clinical Endocrinology|September 6, 2012
A new germline VHL gene mutation in three patients with apparently sporadic pheochromocytomaAngela V D'Elia, Franco Grimaldi, Stefano Pizzolitto, et al.
European Journal of Endocrinology|December 24, 2010
CDKN1B V109G polymorphism a new prognostic factor in sporadic medullary thyroid carcinomaDaniela Pasquali, Luisa Circelli, Antongiulio Faggiano, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|November 11, 2008
Effects of lanreotide Autogel on growth hormone, insulinlike growth factor 1, and tumor size in acromegaly: a 1-year prospective multicenter studyRoberto Attanasio, Roberto Lanzi, Marco Losa, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|December 15, 2017
<i>Italian Association of Clinical Endocrinologists (AME) and Italian AACE Chapter Position Statement for Clinical Practice</i>: Assessment of Response to Treatment and Follow-Up in Gastroenteropancreatic Neuroendocrine NeoplasmsFranco Grimaldi, Nicola Fazio, Roberto Attanasio, et al.
Molecular Genetics and Metabolism|July 14, 2012
CASR gene activating mutations in two families with autosomal dominant hypocalcemiaVito Guarnieri, Angela Valentina D'Elia, Filomena Baorda, et al.
Endocrine|June 25, 2013
Growth hormone values after an oral glucose load do not add clinically useful information in patients with acromegaly on long-term somatostatin receptor ligand treatmentGiuseppe Reimondo, Marta Bondanelli, Maria Rosaria Ambrosio, et al.
Journal of Neuroendocrinology|June 2, 2025
Fragility fractures in well-differentiated gastroenteropancreatic neuroendocrine tumors: Results from a multicentered retrospective studyAlessandro Brunetti, Miriam Cellini, Elisabetta Lavezzi, et al.
Advances in Therapy|November 21, 2023
Optimising Radioligand Therapy for Patients with Gastro-Entero-Pancreatic Neuroendocrine Tumours: Expert Opinion from an Italian Multidisciplinary GroupNicola Fazio, Massimo Falconi, Emanuela Foglia, et al.
Plos One|July 15, 2014
AHR over-expression in papillary thyroid carcinoma: clinical and molecular assessments in a series of Italian acromegalic patients with a long-term follow-upCaterina Mian, Filippo Ceccato, Susi Barollo, et al.
Clinical Endocrinology|December 12, 2012
Cinacalcet in the management of primary hyperparathyroidism: post marketing experience of an Italian multicentre groupFederica Saponaro, Antongiulio Faggiano, Franco Grimaldi, et al.
Pageof 6